EstroGel Articles
Azur launches BioSante's Elestrin in USA
16 April 2009
PharmaSwiss licenses rights to BioSante's Elestrin in Israel
22 December 2008
BioSante reacquires Elestrin rights
18 August 2008
Bradley Pharma debuts Elestrin in USA
18 June 2007
BioSante gets new Elestrin formulation patent
16 April 2007
BioSante swings to $2.8M income in 2006
26 March 2007
Medical literature supports Bradley's low-dose estrogen
12 March 2007
FDA accepts Antares' Bio-E-Gel NDA
1 May 2006
Solvay sees dip in 2004 pharma sales
7 March 2005
FDA clears Solvay's EstroGel
16 February 2004
Estreva Launched In France
13 May 1996
Besins Iscovesco launches Oestrodose
5 June 1995
Showing 1-12 of 12 articles
- 1
- Is failure to adopt business process management putting the pharma industry at risk?
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- New Zealand declines Alexion's funding application for Solaris
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Elan makes "transformational" acquisitions and a divestment
